The model screening preeclampsia at 11+0 to 13+6 weeks of gestation

Abstract

Objective: Screening preeclampsia at 11+0-13+6 gestational by combine maternal characteristics, MAP, PAPP-A and UtAPI. Materials and methods: Prospective screening study for preeclampsia in pregnant attending their first hospital visit at 11-13 weeks 6 of gestation. The performance of screening for PE and GH by combinations of maternal characteristics, uterine artery with the lowest pulsatility index (L-PI), mean arterial pressure (MAP) and serum PAPP-A was determined. Results: Of 2,998 patients with complete outcome data, there were 3.74% of hypertension disorder, and 2.84% cases of pre-eclampsia. The study show a poor results screening for PE by maternal factors only. In screening for PE by combine maternal factors, MAP and L-PI, the estimated detection rates were 18,2% and 45,5% for HG, 45,6% and 57,9% for late PE at a fixed false positive rate of 5% and 10%, respectively. For early PE, in screening by combine maternal characteristics, L-PI, MAP and serum PAPP-A, the the estimated detection rates were 81,8% and 90,9% at at a fixed false positive rate of 5% and 10%, respectively. Conclusion: Effective prediction of early PE can be achieved at 11–13+6 weeks’ gestation by combine maternal characteristics, L-PI, MAP and serum PAPP-A.